.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Future Leaders in Neurology
Spotlight: MS
Spotlight: NMOSD

Clinical FocusSee All >

Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke

Video Series

Cure Connections
Insights
NeurologyLive Peer Exchange
News Network

Advertise
Contact Us
Editorial
Do Not Sell My Information
Terms and Conditions
Privacy
Advisory Board

Management of Cardiac Amyloidosis

EP. 1: Cardiac Amyloidosis Diagnostic Workup

April 30th 2020

EP. 2: Hypertrophic Cardiomyopathy Historical Prognosis

April 30th 2020

EP. 3: AL and ATTR Diagnosis: Echo and Noncardiac Biopsy

April 30th 2020

EP. 4: When Are Heart Biopsies Warranted?

April 30th 2020

EP. 5: Technetium Pyrophosphate Scan Benefits

April 30th 2020

EP. 6: Monoclonal Protein Testing and Wild-Type ATTR

April 30th 2020

EP. 7: Technetium Pyrophosphate Scan Prior to TAVR

April 30th 2020

EP. 8: AL and ATTR Survival Metrics

April 30th 2020

EP. 9: Poor Toleration: AL and ATTR Treatment Modification

April 30th 2020

EP. 10: Cardioversion and Atrial Fibrillation Ablation

April 30th 2020